Dibekacin (3',4'-dideoxykanamycin B) is an
aminoglycoside
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar). The term can also refer ...
antibiotic. It is a semisynthetic derivative of
kanamycin
Kanamycin A, often referred to simply as kanamycin, is an antibiotic used to treat severe bacterial infections and tuberculosis. It is not a first line treatment. It is used by mouth, injection into a vein, or injection into a muscle. Kanamyci ...
developed by
Hamao Umezawa
was a Japanese scientist who discovered several antimicrobial agents and enzyme inhibitors.
Umezawa was born in Obama City, Fukui Prefecture, as the second son in a family of seven children. After graduating from Musashi Junior and Senior High ...
and collaborators for
Meiji Seika
is a Japanese snack food company. It is the trade name of a pharmaceutical company in Japan. It was renamed into the on March 31, 2011. It is currently a subsidiary of Meiji Holdings and a Japanese leader in the area of infectious disease with ...
.
[ ][ ]
It has been used in combination with
sulbenicillin.
[ ]
References
Aminoglycoside antibiotics
{{antibiotic-stub